6-K

SECURITIES AND EXCHANGE COMMISSION
Washington D.C. 20549

FORM 6-K

Report of Foreign Issuer

Pursuant to Rule 13a-16 or 15d-16 of
the Securities Exchange Act of 1934

For the month of November 2008

Commission File Number 000-20181

Sapiens International Corporation N.V.
(translation of registrant’s name into English)

c/o Landhuis Joonchi
Kaya Richard J. Beaujon z/n
P.O. Box 837
Willemstad
Curaçao, Netherlands Antilles
(599) (9) 7366277

(address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F

Form 20-F x Form 40-F o

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ____

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ____

Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2 (b) under the Securities Exchange Act of 1934

Yes o No x

If “Yes” is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82-_______________.



SAPIENS ANNOUNCES Q3 2008 RESULTS WITH NET INCOME FOR
THE FIRST TIME AFTER SEVERAL YEARS OF NET LOSSES

n  Net Income of $803,000 or $0.04 per share (on Non-GAAP basis)
n  Passing the$1 million milestone in operating profit (on Non-GAAP basis)

Cary, N.C. – November 19, 2008 – Sapiens International Corporation N.V. (NASDAQ and TASE: SPNS), a member of the Formula Group (NASDAQ: FORTY and TASE: FORT), today announced its results of operations for the third quarter ending September 30, 2008.

Highlights for Q3 2008

  Revenue for the third quarter of 2008 reached $11 million, an increase of 5% compared to $10.5 million in the third quarter of 2007.

  This is the eighth consecutive quarter of operating profit, which amounted, in the third quarter of 2008, to $709,000, a significant increase of 283% compared to $185,000 in the third quarter of 2007.

  First time reporting net income of $375,000 after several years of losses.

  Strong cash position with total cash and cash equivalents of $11.9 million and Shareholders’ equity of $22 million.

  Cash flow from operations for the third quarter of 2008 is approximately $2 million.

  Increase in pipe line from the insurance sector and renewing agreements with existing customers.

  Non-GAAP

  Operating profit of $1,137,000, passing the $1 million milestone and a 155% improvement compared to the third quarter of 2007.

  Net income of $803,000, a significant improvement compared to a loss of $28,000 in the third quarter of 2007.

  U.S. GAAP

  Operating profit of $709,000, a 283% increase compared to the third quarter of 2007.

  Net income of $375,000, compared to a net loss of $288,000 in the third quarter of 2007.



Roni Al-Dor, President and CEO, commented “I am pleased to report on another strong quarter, in which we achieved on-track growth in our revenues, operating profit, and first time net income after several years of losses.

The efficiency measures we implemented in the company and the constant focus on improving our products and offering are coming to fruition resulting in net income of $803,000 on a Non-GAAP basis for the third quarter after several years of losses. In the last eight quarters, we showed constant improvement in our operational profit, which this quarter reached, on a Non-GAAP basis, a record of over $1 million.

In the third quarter, we generated $2 million in cash from operations thereby improving our financial position. Despite the general market climate, we are competing in several major promising opportunities in Israel, USA, UK and Japan which we expect will become signed agreements in the near future. In addition, we see an increased interest in our insurance product line, namely, the Insight for Life and Pension, Insight for Policy and Claims and Insight for Re-Insurance. These achievements reinforce our strategy direction and the improved performance which will allow us to continue the growth momentum.

We have expanded our strategic avenues and are well positioned to pursue options for organic and/or inorganic growth. At the same time, while we are pleased with our financial momentum and remain optimistic regarding the future, we continue to closely monitor the economic climate and to consider ways to address the specific needs of our partners and customers.”

Reconciliation between U.S. GAAP and Non-GAAP results is summarized in the following table. For a complete reconciliation, please refer to the tables at the end of this release.

  U.S. Dollars in thousands, except per share amounts

For the three months ended
For the nine months ended
09/30/2008
09/30/2007
09/30/2008
09/30/2007
(Unaudited)
(Unaudited)
(Unaudited)
(Unaudited)
 
U.S GAAP basis                    
   
Revenues    11,024    10,532    32,527    32,219  




Operating profit    709    185    1,711    496  




Net income (loss)    375    (288 )  (1,351 )  (1,408 )




Basic earning (loss) per share    0.02    (0.01 )  (0.06 )  (0.08 )




Diluted earning (loss) per share    0.02    (0.01 )  (0.06 )  (0.08 )




   
Non-GAAP basis   
   
Revenues    11,024    10,532    32,527    32,219  




Operating profit    1,137    445    2,348    386  




Net income (loss)    803    (28 )  (714 )  (1,518 )




Basic earning (loss) per share    0.04    (0.00 )  (0.03 )  (0.09 )




Diluted earning (loss) per share    0.04    (0.00 )  (0.03 )  (0.09 )







U.S. GAAP results include amortization of capitalized software developments, capitalization of software development costs, and stock-based compensation expenses.

Comment Regarding Non-GAAP
Sapiens’ management believes that the presentation of non-GAAP measures can enhance the understanding of the company’s ongoing economic performance, and provides useful information to investors regarding financial and business trends relating to the company’s financial condition and results of operations. Sapiens therefore uses internally the non-GAAP information to evaluate and manage the Company’s operations.

This non-GAAP financial measures are not in accordance with, or an alternative for, generally accepted accounting principles and may be different from non-GAAP financial measures used by other companies. In addition, these non-GAAP financial measures are not based on any comprehensive set of accounting rules or principles. Sapiens believes that non-GAAP financial measures have limitations in that they do not reflect all of the amounts associated with Sapiens’ results of operations as determined in accordance with GAAP and that these measures should only be used to evaluate Sapiens’ results of operations in conjunction with the corresponding GAAP measures.

Please refer to the Reconciliation of GAAP to Non-GAAP Results at the end of this release.

FOR ADDITIONAL INFORMATION:  
Roni Giladi Roni Al-Dor
Chief Financial Officer Chief Executive Officer
Sapiens International Sapiens International
Tel: +972-8-938-2721 Tel: +972-8-938-2721
E-mail: IR.Sapiens@sapiens.com E-mail: IR.Sapiens@sapiens.com

About Sapiens International
Sapiens International Corporation N.V. (Nasdaq and TASE: SPNS), a member of Formula Group (Nasdaq: FORTY and TASE: FORT), which is a member of the Emblaze Group (LSE: BLZ.L) is a leading global provider of proven IT solutions that modernize business processes and enable insurance organizations to adapt quickly to change. Sapiens’ innovative solutions are widely recognized for their ability to cost-effectively align IT with the business demands for speed, flexibility and efficiency. Sapiens operates through its subsidiaries in North America, the United Kingdom, EMEA and Asia Pacific, and has partnerships with market leaders such as IBM and EDS. Sapiens’ clients include AXA, ING, Liverpool Victoria, Menora Mivtachim, Norwich Union, Occidental Fire & Casualty, OneBeacon, Principal Financial Group, Santam and Texas Farm Bureau among others. For more information, please visit http://www.sapiens.com.

Except for historical information contained herein, the matters set forth in this release are forward-looking statements that are dependent on certain risks and uncertainties, including such factors, among others, as market acceptance, market demand, pricing, changing regulatory environment, changing economic conditions, risks in new product and service development, the effect of the Company’s accounting policies, specific system configurations and software needs of individual customers and other risk factors detailed in the Company’s SEC filings.



SAPIENS INTERNATIONAL CORPORATION N.V.
Condensed Consolidated Balance Sheets
(U.S. Dollars in thousands)

9/30/2008
12/31/2007
(Unaudited)
(Audited)
 
Assets            
   
     Cash and cash equivalents   $ 11,891   $ 13,125  
     Trade receivables, net    7,845    7,549  
     Other current assets    2,963    1,881  


     Total current assets     22,699    22,555  


   
     Property and equipment, net    1,160    1,219  
     Other assets, net    29,410    28,758  


Total assets    $ 53,269   $ 52,532  


   
Liabilities and shareholders' equity   
   
     Short-term bank credit and current maturities  
        of long-term debt and convertible debentures   $ 5,379   $ 9,456  
     Trade payables    1,681    1,088  
     Other liabilities and accrued expenses    10,340    8,375  
     Deferred revenue    6,271    4,203  


     Total current liabilities     23,671    23,122  


   
     Long-term debt and other long-term liabilities    1,574    1,132  
     Convertible debentures and warrants    5,855    6,428  
     Shareholders' equity    22,169    21,850  


Total liabilities and shareholders' equity    $ 53,269   $ 52,532  





SAPIENS INTERNATIONAL CORPORATION N.V.
Condensed Consolidated Statements of Operations
(U.S. Dollars in thousands, except per share amounts)

For the three months ended
For the nine months ended
09/30/2008
09/30/2007
09/30/2008
09/30/2007
Unaudited
Unaudited
Unaudited
Unaudited
 
Revenues     $ 11,024   $ 10,532   $ 32,527   $ 32,219  
   
Cost of revenues    $ 6,649   $ 6,573   $ 19,447   $ 20,498  




   
Gross Profit     4,375    3,959    13,080    11,721  
   
Operating expenses   
Research and development, net   $ 885   $ 703   $ 2,532   $ 1,679  
Selling, marketing, general and administrative   $ 2,781   $ 3,071   $ 8,837   $ 9,546  




   
Operating Profit     709    185    1,711    496  
   
Financial expenses, net   $ 299   $ 515   $ 2,484   $ 1,631  
Other expenses (income), net (a)   $ 35   $ (42 ) $ 578   $ 273  




   
Net Income (Loss)    $ 375   $ (288 ) $ (1,351 ) $ (1,408 )




   
Earning (loss) per share  
Basic   $ 0.02   $ (0.01 ) $ (0.06 ) $ (0.08 )




Diluted   $ 0.02   $ (0.01 ) $ (0.06 ) $ (0.08 )




   
Weighted average number of shares used to computation  
of earning (loss) per share  
Basic    21,541    20,853    21,541    17,095  




Diluted    21,545    20,853    21,541    17,095  





  Note a: Includes taxes, equity losses, minority interest and capital losses due to repurchase of debentures.



SAPIENS INTERNATIONAL CORPORATION N.V.
Reconciliation of GAAP to Non-GAAP results
(U.S. Dollars in thousands, except per share amounts)

For the three months ended
For the nine months ended
09/30/2008
09/30/2007
09/30/2008
09/30/2007
(Unaudited)
(Unaudited)
(Unaudited)
(Unaudited)
 
GAAP operating profit      709    185    1,711    496  
Amortization of intangibles    1,233    1,059    3,235    3,127  
Capitalization of software development costs    (855 )  (849 )  (2,713 )  (3,324 )
Stock-based compensation    50    50    115    87  




Total adjustments to GAAP    428    260    637    (110 )




Non-GAAP operating profit    1,137    445    2,348    386  




   
GAAP net income (loss)    375    (288 )  (1,351 )  (1,408 )
Total adjustments to GAAP as above    428    260    637    (110 )




Non-GAAP net income (loss)    803    (28 )  (714 )  (1,518 )




   
Non-GAAP basic earnings (loss) per share    0.04    (0.00 )  (0.03 )  (0.09 )




   
Non-GAAP diluted earnings (loss) per share    0.04    (0.00 )  (0.03 )  (0.09 )




   
Weighted average number of ordinary shares used in  
computing basic net earnings (loss) per ordinary share    21,541    20,853    21,541    17,095  




   
Weighted average number of ordinary shares used in  
computing diluted net earnings (loss) per ordinary share    21,545    20,853    21,541    17,095  







SIGNATURE

        Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.




Date: November 19, 2008
Sapiens International Corporation N.V.
(Registrant)

By: /s/ Roni Giladi
——————————————
Roni Giladi
Chief Financial Officer